FDA awards Neuralert Technologies Breakthrough Device designation

News Item
FDA awards Neuralert Technologies Breakthrough Device designation
Monday, August 2, 2021

Congratulate to Jim, Co-Founder of Neuralert Technologies, LLC -- a wearable medical device company that detects symptoms of potential stroke, on getting FDA designation for device, identifies potential lead investor. Their system uses non-invasive, wearable devices which accurately detect stroke symptoms and then alerts clinical staff to more rapidly initiate stroke mitigating treatments.